PLCG2 and neoplasm: In vitro experiments demonstrated that MK2206 could reverse the biological effects of overexpression of PLCG2 on increasing tumor cell proliferation, migration, and invasion, and decreasing apoptosis, whereas SC79 could reverse the biological effects of knockdown of PLCG2 on regulating certain phenotypes (Figure 8C, D, E).